title: Case report of papillary breast carcinoma, cystic.
abstract: Intracystic papillary carcinoma of the breast (ICP) is a rare form of noninvasive breast cancer. The average age of onset is 65 years. Patients with ICP have a greater than 15-year survival rate advantage compared to patients with other breast carcinomas. There have been no reports of disease-related deaths in patients with ICP and no increased risk of disease in the contralateral breast. No definitive conclusions have been made regarding adjuvant treatment; however, ICP should generally be treated like ductal carcinoma in situ (DCIS). Tamoxifen is often recommended.
authors: Department of Family Medicine, Sanford School of Medicine, University of South Dakota, USA.
authors: Susan
authors: S
authors: Anderson
authors: Thomas
authors: T
authors: Cink
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000628:therapy*; D002291:Carcinoma, Papillary / Q000000981:diagnostic imaging / Q000628:therapy*; D005260:Female; D006801:Humans; D008408:Mastectomy; D008875:Middle Aged; D021701:Sentinel Lymph Node Biopsy; D013629:Tamoxifen / Q000627:therapeutic use*; D014463:Ultrasonography
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen